Top Markets
Coin of the day
Oxurion N.V. Oxurion N.V.

Oxurion N.V.

OXUR
Classement en actions #39567
Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a... Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a biopharmaceutical firm focused on researching, developing, and bringing to market treatments for various ocular conditions worldwide. Its primary commercialized offering is JETREA, a medication used to address vitreomacular adhesion and vitreomacular traction. The company's development pipeline includes THR-149, a plasma kallikrein inhibitor currently undergoing Phase II clinical trials for diabetic macular edema (DME), and THR-687, an integrin antagonist also in Phase II trials for DME. Oxurion has forged strategic partnerships with Bicycle Therapeutics, INC Research, and Galapagos NV. The organization was formerly known as ThromboGenics NV before officially changing its name to Oxurion NV in September 2018.
Prix de l'action
$0.003084
Capitalisation boursière
$434.03K
Changement (1 jour)
-7.14%
Changement (1 an)
-89.24%
Pays
BE
Échange Oxurion N.V. (OXUR)

Catégorie

Historique du prix de l'action pour Oxurion N.V. (OXUR)
Prix de clôture le plus élevé : $0.00 le 2026-08-01

Prix de clôture le plus bas : $62.97K le 2006-07-01
Historique du prix de l'action de Oxurion N.V. de 2006 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 5.23%
2025 -96.55%
2024 -97.10%
2023 -94.05%
2022 -99.22%
2021 -35.88%
2020 10.67%
2019 -29.09%
2018 -4.13%
2017 62.47%
2016 -25.93%
2015 -55.06%
2014 -66.50%
2013 -54.24%
2012 123.36%
2011 -17.09%
2010 25.57%
2009 132.05%
2008 -27.90%
2007 10.78%
2006 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$517.18 32.51%
US
$857.76 31.47%
NL
$733.78 7.43%
CH
$1.07K -6.40%
KR
$260.01 14.86%
BE